146 related articles for article (PubMed ID: 21705677)
1. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
Egom EE; Mohamed TM; Mamas MA; Shi Y; Liu W; Chirico D; Stringer SE; Ke Y; Shaheen M; Wang T; Chacko S; Wang X; Solaro RJ; Fath-Ordoubadi F; Cartwright EJ; Lei M
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1487-95. PubMed ID: 21705677
[TBL] [Abstract][Full Text] [Related]
2. Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection.
Zhao X; Ding EY; Yu OM; Xiang SY; Tan-Sah VP; Yung BS; Hedgpeth J; Neubig RR; Lau LF; Brown JH; Miyamoto S
J Mol Cell Cardiol; 2014 Oct; 75():152-61. PubMed ID: 25106095
[TBL] [Abstract][Full Text] [Related]
3. Ventricular SK2 upregulation following angiotensin II challenge: Modulation by p21-activated kinase-1.
Yang B; Jiang Q; He S; Li T; Ou X; Chen T; Fan X; Jiang F; Zeng X; Huang CL; Lei M; Tan X
J Mol Cell Cardiol; 2022 Mar; 164():110-125. PubMed ID: 34774547
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling.
Egom EE; Ke Y; Solaro RJ; Lei M
Prog Biophys Mol Biol; 2010 Sep; 103(1):142-7. PubMed ID: 20080123
[TBL] [Abstract][Full Text] [Related]
5. Cardiac deficiency of P21-activated kinase 1 promotes atrial arrhythmogenesis in mice following adrenergic challenge.
Jung E; Capel R; Jiang C; Venturi E; Neagu G; Pearcey S; Zhou Y; Zhang Y; Lei M
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220168. PubMed ID: 37122217
[TBL] [Abstract][Full Text] [Related]
6. Functional integrity of the T-tubular system in cardiomyocytes depends on p21-activated kinase 1.
DeSantiago J; Bare DJ; Ke Y; Sheehan KA; Solaro RJ; Banach K
J Mol Cell Cardiol; 2013 Jul; 60():121-8. PubMed ID: 23612118
[TBL] [Abstract][Full Text] [Related]
7. Development of a Cell Co-Culture Model to Mimic Cardiac Ischemia/Reperfusion In Vitro.
Li Z; Hampton MJW; Barajas MB; Riess ML
J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723947
[TBL] [Abstract][Full Text] [Related]
8. Platelet Function is Independent of Sphingolipid Manipulation.
Wallen TE; Morris M; Ammann A; Baucom MR; Price A; Schuster R; Makley AT; Goodman MD
J Surg Res; 2024 May; 300():25-32. PubMed ID: 38795670
[TBL] [Abstract][Full Text] [Related]
9. 1-Phosphate receptor agonists: A promising therapeutic avenue for ischemia-reperfusion injury management.
Wang L; Zhang X; Ma C; Wu N
Int Immunopharmacol; 2024 Apr; 131():111835. PubMed ID: 38508097
[TBL] [Abstract][Full Text] [Related]
10. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
Liu W; Zi M; Naumann R; Ulm S; Jin J; Taglieri DM; Prehar S; Gui J; Tsui H; Xiao RP; Neyses L; Solaro RJ; Ke Y; Cartwright EJ; Lei M; Wang X
Circulation; 2011 Dec; 124(24):2702-15. PubMed ID: 22082674
[TBL] [Abstract][Full Text] [Related]
11. Pak1 is required to maintain ventricular Ca²⁺ homeostasis and electrophysiological stability through SERCA2a regulation in mice.
Wang Y; Tsui H; Ke Y; Shi Y; Li Y; Davies L; Cartwright EJ; Venetucci L; Zhang H; Terrar DA; Huang CL; Solaro RJ; Wang X; Lei M
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):938-48. PubMed ID: 25217043
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide.
Wang R; Wang Y; Lin WK; Zhang Y; Liu W; Huang K; Terrar DA; Solaro RJ; Wang X; Ke Y; Lei M
PLoS One; 2014; 9(7):e101974. PubMed ID: 25014109
[TBL] [Abstract][Full Text] [Related]
13. p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes.
DeSantiago J; Bare DJ; Xiao L; Ke Y; Solaro RJ; Banach K
J Mol Cell Cardiol; 2014 Feb; 67():77-85. PubMed ID: 24380729
[TBL] [Abstract][Full Text] [Related]
14. Role of p21-activated kinases in cardiovascular development and function.
Kelly ML; Astsaturov A; Chernoff J
Cell Mol Life Sci; 2013 Nov; 70(22):4223-8. PubMed ID: 23640572
[TBL] [Abstract][Full Text] [Related]
15. P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma.
Ong CC; Jubb AM; Jakubiak D; Zhou W; Rudolph J; Haverty PM; Kowanetz M; Yan Y; Tremayne J; Lisle R; Harris AL; Friedman LS; Belvin M; Middleton MR; Blackwood EM; Koeppen H; Hoeflich KP
J Natl Cancer Inst; 2013 May; 105(9):606-7. PubMed ID: 23535073
[TBL] [Abstract][Full Text] [Related]
16. Novel roles of PAK1 in the heart.
Ke Y; Lei M; Wang X; Solaro RJ
Cell Logist; 2012 Apr; 2(2):89-94. PubMed ID: 23162741
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of fingolimod.
David OJ; Kovarik JM; Schmouder RL
Clin Pharmacokinet; 2012 Jan; 51(1):15-28. PubMed ID: 22149256
[TBL] [Abstract][Full Text] [Related]
18. P21-activated kinase-1 signaling is required to preserve adipose tissue homeostasis and cardiac function.
Munoz M; Solis C; McCann M; Park J; Rafael-Clyke K; Chowdhury SAK; Jiang Y; Rosas PC
Mol Cell Biochem; 2024 Mar; ():. PubMed ID: 38430300
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
